semaglutide 5mg vial — Selective GLP-1 Receptor Agonist — Research Peptide – Prime Labs Semaglutide/B12 Injectable (2mL vial) |

[15] In January 2022, Wegovy was approved for medical use in the European Union

These medications help with type 2 diabetes while also working on your brain and digestive system to control your appetite, support weight loss, and lower the risk of heart-related diseases

At our Houston clinic, every protocol is fully personalized, carefully monitored, and integrated with nutrition, movement, and lifestyle strategy

Some patients and clinicians prematurely conclude the medication is ineffective before reaching therapeutic doses of 10-15 mg weekly

For a deeper look at this process, see our article on how semaglutides support weight loss

The GLP-1 family acts heavily on the gut-brain axis through slowed digestion and reduced hunger signalling